Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the Oxford University Clinical Research Unit in Vietnam have completed what is probably the largest ever controlled trial of tuberculous meningitis. The study is published in the New England Journal of Medicine.

CTMGH logo for News

Researchers from the Oxford University Clinical Research Unit in Vietnam have completed what is probably the largest ever controlled trial of tuberculous meningitis. The study is published in the New England Journal of Medicine

Tuberculous meningitis is the most destructive form of the disease, with tuberculosis bacteria infecting the thin sheaths covering the central nervous system, resuling in fever and headaches. One third of infected patients die, despite current treatment. 

Guy Thwaites and his colleagues therefore tested whether an intensified antituberculosis treatment (higher doses of a currently used antibiotic, rifampin, combined with another antibiotic, levofloxacin) might help improve survival rates.